Posttransplant bone disease: evidence for a high bone resorption state
- PMID: 11152104
- DOI: 10.1097/00007890-200012270-00011
Posttransplant bone disease: evidence for a high bone resorption state
Abstract
Loss of bone is a significant problem after renal transplant. Although bone loss in the first post transplant year has been well documented, conflicting data exist concerning bone loss after this time. It is equally unclear whether bone loss in long-term renal transplant recipients correlates with bone turnover as it does in postmenapausal osteoporosis. To examine these issues, we conducted a cross-sectional study to define the prevalence of osteoporosis in long-term (> 1 year) renal transplant recipients with preserved renal function (mean creatinine clearance 73 +/- 23 ml/min). Bone mineral density (BMD) was measured at the hip, spine and wrist by DEXA in 69 patients. Markers for bone formation (serum osteocalcin) and bone resorption [urinary levels of pyridinoline (PYD) and deoxypyridinoline (DPD)] were also measured as well as parameters of calcium metabolism. Correlations were made between these parameters and BMD at the various sites. The mean age of the patients was 45 +/- 11 years. Eighty eight percent of patients were on cyclosporine (12% on tacrolimus) and all but 2 were on prednisone [mean dose 9 +/- 2 mg/day)]. Osteoporosis (BMD more than 2.5 SD below peak adult BMD) at the spine or hip was diagnosed in 44% of patients and osteopenia was present in an additional 44%. Elevated levels of intact parathyroid hormone (i PTH) were observed in 81% of patients. Elevated urinary levels of PYD or DPD were present in 73% of patients and 38% had elevated serum levels of osteocalcin. Levels of calcium, and of 25(OH) and 1,25(OH)2 vitamin D were normal. In a stepwise multiple regression model that included osteocalcin, PYD, DPD, intact PTH, age, years posttransplant, duration of dialysis, cumulative prednisone dose, smoking, and diabetes: urinary PYD was the strongest predictor of bone mass. These results demonstrate that osteoporosis is common in long-term renal transplant recipients. The data also suggest that elevated rates of bone resorption contribute importantly to this process.
Similar articles
-
Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.Transplantation. 2001 Jul 15;72(1):83-8. doi: 10.1097/00007890-200107150-00017. Transplantation. 2001. PMID: 11468539
-
Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.Osteoporos Int. 2005 Feb;16(2):142-8. doi: 10.1007/s00198-004-1653-y. Epub 2004 Jul 16. Osteoporos Int. 2005. PMID: 15258722
-
Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.Kidney Int. 2000 Oct;58(4):1788-96. doi: 10.1046/j.1523-1755.2000.00341.x. Kidney Int. 2000. PMID: 11012914 Clinical Trial.
-
Alcoholic liver disease and changes in bone mineral density.Rev Esp Enferm Dig. 2013 Nov-Dec;105(10):609-21. doi: 10.4321/s1130-01082013001000006. Rev Esp Enferm Dig. 2013. PMID: 24641458 Review.
-
Mineral and Bone Disease in Kidney Transplant Recipients.Curr Osteoporos Rep. 2018 Dec;16(6):703-711. doi: 10.1007/s11914-018-0490-4. Curr Osteoporos Rep. 2018. PMID: 30390201 Review.
Cited by
-
Bone mineral density in live related kidney transplant children and adolescents.Int Urol Nephrol. 2004;36(1):95-100. doi: 10.1023/b:urol.0000032694.80134.5f. Int Urol Nephrol. 2004. PMID: 15338684
-
Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.J Transplant. 2014;2014:269613. doi: 10.1155/2014/269613. Epub 2014 Feb 19. J Transplant. 2014. PMID: 24696777 Free PMC article.
-
Osteoporosis in patients with diabetes after kidney transplantation.Rev Endocr Metab Disord. 2017 Mar;18(1):97-106. doi: 10.1007/s11154-016-9397-5. Rev Endocr Metab Disord. 2017. PMID: 27866309 Review.
-
Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant's Recipients: A Systematic Review.Medicina (Kaunas). 2021 May 23;57(6):525. doi: 10.3390/medicina57060525. Medicina (Kaunas). 2021. PMID: 34071098 Free PMC article.
-
Vitamin D receptor polymorphisms and bone health after kidney transplantation.Turk J Med Sci. 2021 Apr 30;51(2):802-812. doi: 10.3906/sag-1911-156. Turk J Med Sci. 2021. PMID: 33306336 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical